Showing results (281-290 of 306) with videos related to
Sort By:
Pageof 31
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 14, 2025
Repositioning Radiation Oncology at the centre of integrated oncology care: A manifesto of the European Society for Radiotherapy and Oncology (ESTRO)Icro Meattini, Marianne C Aznar, Luca Boldrini, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2020
Phantom-based quality assurance for multicenter quantitative MRI in locally advanced cervical cancerPetra J van Houdt, Jesper F Kallehauge, Kari Tanderup, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 5, 2020
ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortiumErnst S Kooreman, Petra J van Houdt, Rick Keesman, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 1, 2026
ESTRO's principles for environmental sustainability in the radiation oncology communityKari Tanderup, Anna M Kirby, Jesper Grau Eriksen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2021
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III TrialLinda G W Kerkmeijer, Veerle H Groen, Floris J Pos, et al.Physics and Imaging in Radiation Oncology|January 18, 2021
Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear acceleratorMariska D den Hartogh, Hans C J de Boer, Eline N de Groot-van Breugel, et al.Annals of Internal Medicine|April 15, 1996
The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trialA van der Heide, J W Jacobs, J W Bijlsma, et al.Practical Radiation Oncology|May 4, 2021
68Ga-PSMA-11 PET, 18F-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer VariabilityCédric Draulans, Floris Pos, Robert J Smeenk, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2024
Intra-prostatic recurrences after radiotherapy with focal boost: Location and dose mapping in the FLAME trialK Menne Guricová, F J Pos, I G Schoots, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2021
Anorectal dose-effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trialVeerle H Groen, Nicolaas P A Zuithoff, Marcel van Schie, et al.Pageof 31